$24.94 0.6%
PFE Stock Price vs. AI Score
Data gathered: November 20

AI Score



Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

AI Stock Analysis - Pfizer (PFE)

Analysis generated October 16, 2024. Powered by Chat GPT.

Pfizer Inc. is one of the world's premier biopharmaceutical companies, known for its production of vaccines, such as the widely recognized COVID-19 vaccine. Its diverse portfolio encompasses a range of pharmaceutical products catering to various medical fields including oncology, cardiology, neurology, and endocrinology.

Read full AI stock Analysis

Stock Alerts - Pfizer (PFE)

company logo Pfizer | November 20
Sentiment is up by 11.7% in the last couple of days.
company logo Pfizer | November 16
AI Score is up by 23% in the last couple of days.
company logo Pfizer | November 16
Reddit mentions are up by 189% in the last 24h.
company logo Pfizer | November 15
Price is down by -5.6% in the last 24h.

About Pfizer

Pfizer Inc is a biopharmaceutical company that discovers, develops, manufactures, and markets healthcare products including medicines, and vaccines as well as many of the consumer healthcare products.


Pfizer
Price $24.94
Target Price Sign up
Volume 46,000,000
Market Cap $141B
Year Range $24.17 - $30.9
Dividend Yield 6.77%
PE Ratio 33.15
Analyst Rating 35% buy
Industry Drug Manufacturers

In the news


Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda EPS
Q3 '2417.7B8.72B8.98B4.47B6.78B1.060
Q2 '2413.3B8.41B4.88B41M1.99B0.600
Q1 '2414.9B8.28B6.6B3.12B5.5B0.820
Q4 '2314.2B18.1B-3.89B-3.37B-2.28B0.100
Q3 '2313.5B12.6B625M-2.38B-1.45B-0.170

Insider Transactions View All

DAMICO JENNIFER B. filed to sell 8,582 shares at $28.7.
August 14 '24
Gottlieb Scott filed to buy 9,000 shares at $26.5.
December 19 '23
Gottlieb Scott filed to buy 6,000 shares at $38.6.
May 9 '23
DAMICO JENNIFER B. filed to sell 9,003 shares at $40.
March 17 '23
DAMICO JENNIFER B. filed to sell 10,846 shares at $54.
June 8 '22

What is the Market Cap of Pfizer?

The Market Cap of Pfizer is $141B.

What is Pfizer's PE Ratio?

As of today, Pfizer's PE (Price to Earnings) ratio is 33.15.

What is the current stock price of Pfizer?

Currently, the price of one share of Pfizer stock is $24.94.

How can I analyze the PFE stock price chart for investment decisions?

The PFE stock price chart above provides a comprehensive visual representation of Pfizer's stock performance over time. Investors can use this chart to identify patterns, trends, and potential support or resistance levels. By examining historical data and recent price movements, investors can make more informed decisions regarding buying, holding, or selling Pfizer shares. Our platform offers an up-to-date PFE stock price chart, along with technical data analysis and alternative data insights.

Does PFE offer dividends to its shareholders?

Yes, Pfizer (PFE) offers dividends to its shareholders, with a dividend yield of 6.77%. This dividend yield represents Pfizer's commitment to providing value to its shareholders through both potential capital appreciation and steady income. Investors considering Pfizer in their portfolio should factor in this dividend policy alongside the company's growth prospects and market position.

What are some of the similar stocks of Pfizer?

Some of the similar stocks of Pfizer are Johnson & Johnson, Eli Lilly and Company, Astrazeneca, AbbVie, and TherapeuticsMD.

.
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.